CMTF International Assisted Reproduction Conference
—2025 International Assisted Reproduction Exhibition
Date: November 13-15, 2025
Venue: China International Exhibition Center (Chaoyang Pavilion), Beijing
I. Introduction
Currently, reproductive health issues in my country are becoming increasingly prominent. The infertility rate is on the rise, currently reaching approximately 18%. Approximately one in every seven to eight couples of childbearing age faces fertility difficulties. Among the over 40 million infertile patients, approximately 20% require assisted reproductive technology (ART) to resolve their fertility challenges.
Due to factors such as my country's aging population, changing fertility attitudes, the liberalization of fertility policies, and the inclusion of ART in medical insurance, the market penetration of ART is expected to further increase. It is estimated that by 2025, the ART service market will reach 85.43 billion yuan, approaching the 100 billion yuan mark.
To promote international exchange and cooperation in assisted reproductive medicine, explore cutting-edge research in reproductive medicine, improve clinicians' diagnostic and treatment capabilities, and promote the popularization and application of reproductive technology, the CMTF International Assisted Reproduction Conference, organized by Zhenghe Exhibition Group, will be held at the China International Exhibition Center in Beijing from November 13th to 15th. International reproductive hospitals and IVF centers from over 30 countries and regions will participate, allowing professional visitors to connect with renowned doctors and hospitals worldwide without leaving their home country, providing them with more options.
In addition, the CMTF International Assisted Reproduction Conference will be held again in 2026, from March 4th to 5th at the Chengdu Marriott Hotel, from April 23rd to 25th at the Shanghai Exhibition Center, from July 16th to 18th at the Shenzhen Convention and Exhibition Center, and in November at the Beijing China International Exhibition Center. The conference will continue to integrate resources and empower the international assisted reproductive industry in the long term!
II. Exhibition Highlights
1. The exhibition area features fertility centers from around the world, showcasing their respective technologies, treatment processes, and supporting services.
Mainland China, the United States, the United Kingdom, Japan, Thailand, Malaysia, Greece, Australia, Colombia, Italy, South Korea, Laos, Singapore, Russia, India, Ukraine, Georgia, Kazakhstan, Kyrgyzstan, the Middle East, Turkey, and Hong Kong, Macau, and Taiwan (China).
At the exhibition, channel visitors can find like-minded partners. Families seeking fertility can also access one-stop consultation, compare prices, and select the right service provider to address their fertility challenges.
2. The forum area brings together fertility experts and industry leaders from around the world to exchange technologies, share experiences, and gain insights into policies and markets.
Topics will cover hot topics across the entire assisted reproductive technology chain, referencing cutting-edge industry trends, balancing professional depth with public interest. Discussions will focus on topics such as "opportunities for policy and market collaboration, technological breakthroughs and safety, international assistance and cross-border services, patient care and theoretical practice, and cutting-edge technological innovations and improving the patient experience."
Theme 1: Sharing Policy and Market Cooperation Opportunities
1. With the relaxation of fertility policies unlocking the market and personalized patient needs, how can fertility centers at home and abroad integrate and empower themselves to meet this market demand? How can they achieve standardized operations and sustainable development?
—Comparing and contrasting global fertility policies to explore opportunities for cross-border cooperation; collaborating domestically and internationally to address patients' fertility challenges, providing them with greater peace of mind, confidence, and security when seeking medical care!
2. Generation Z is reluctant to have children, while those who want to have them are unable to. The existing market is struggling to stimulate growth. How can we overcome this dilemma and achieve incremental business growth?
—Helping attendees expand high-quality channels and partners, break regional restrictions, and achieve a second growth curve for their business!
3. Opportunities and Challenges of Assisted Reproduction After National Medical Insurance Coverage
—Analyzing the changes in patient penetration, reimbursement differences, and institutional response strategies after assisted reproduction was included in medical insurance in 31 provinces (referring to the current medical insurance reimbursement rate of 50%-70%).
4. Interpretation of the Draft "Regulations on the Management of Assisted Reproductive Technology" and Compliance Practices
—Exploring the impact of legislative progress on the regulation of institutional qualifications and technical ethics.
5. Policy Barriers and Breakthroughs for Cross-Border Assisted Reproductive Services
—Analyzing policy differences in popular regions such as Southeast Asia and the United States, and exploring how to serve Chinese patients.
6. Differentiated Competitive Strategies of Private vs. Public Reproductive Centers
—Discussing how to optimize service models under medical insurance cost control (e.g., high-end customization, success rate guarantee plans).
Theme 2: Sharing Technological Breakthroughs and Safety Assurances
1. Breaking Through the Bottleneck of Advanced Fertility: New Advances in Oocyte Cryopreservation and Activation Technologies
—Announcement of a plan to increase live birth rates for women over 35 (domestic live birth rates are only 40%-50%).
2. Best Practices for the Prevention and Treatment of Ovarian Hyperstimulation Syndrome
—Sharing clinical protocols that reduce the incidence of ovarian hyperstimulation syndrome by 10%-20%.
3. Multidisciplinary Diagnosis and Treatment Pathways for Recurrent Implantation Failure (RIF)
—Combining immunotherapy and endometrial receptivity assessment to improve implantation rates.
4. Application Prospects and Clinical Transformation of Stem Cell Therapy in Reproductive Medicine
—Discussing breakthrough cases in premature ovarian failure and endometrial repair.
Theme 3: Exploring International Collaboration and Cross-Border Services
1. Comparison of Success Rates and Technological Complementarity among Reproductive Centers in China, the United States, Thailand, and Japan
—Analysis of each country's strengths (e.g., the 70% PGTA pregnancy rate in the United States vs. Japan's compatibility with Asian populations).
2. Legal Risk Prevention and Rights Protection Guide for Cross-Border Medical Care
—How is cross-border medical care guaranteed?
3. Belt and Road Reproductive Medical Care Cooperation: The Case of the China-Laos-Thailand Border Medical Special Zone
—Sharing experiences in developing cross-border reproductive services in Belt and Road countries and elsewhere.
Theme 4: Sharing Patient Care and Ethical Practices
1. Psychological Crisis Intervention in Assisted Reproduction: Building a Support System for the 67% of Anxious Patients
—How institutions provide psychological counseling and couple relationship support.
2. Risk Management of Multiple Pregnancy: From a 50% Premature Birth Rate in Twins to Selective Fetal Reduction
—Pregnancy Management Plans Patients Need to Know.
3. Long-Term Health Tracking for IVF: Managing the Risks of Metabolic Syndrome
—Publishing Child Development Follow-up Data and Health Management Recommendations.
4. Protecting Women's Reproductive Rights: Fertility Preservation Technologies
Theme 5: Forward-Looking Technological Innovation and Optimizing the Patient Experience
1. AI-Powered Personalized Ovulation Stimulation Program Design
— Predicting ovarian response through big data and reducing medication costs.
2. Transparent Service Revolution: Application of a Time-Lapse Embryo Culture Real-Time Monitoring System
— Demonstrating technologies to enhance patient trust.
3. Comprehensive Management for Improving Success Rates
— Uncovering the impact of nutritional supplements and acupuncture on success rates, and the safety net provided by IVF insurance.
III. Exhibition Objectives
Through multi-faceted sharing and discussion, the exhibition aims to:
1) Promote international exchange and learning on reproductive technology, explore pain points and breakthroughs in reproductive technology, and share clinical cases, industry hot topics, trends, and opportunities;
2) Bring new hope to patients with infertility caused by various factors;
3) Deepen international cooperation in the reproductive industry;
4) Explore standardized business strategies for the reproductive industry, address industry pain points, and help practitioners achieve sustainable and healthy development;
5) Explore how practitioners can overcome difficulties and achieve business growth in the existing market;
IV. For exhibition participation/visits, please contact:
Conference Organizer: Zhenghe Exhibition Group
Conference Official Website: https://www.cmtf.net/
Official Hotline: 02084138131
